Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Celgene Corp. Contingent Value Rt

TRADE

NASDAQ: CELGZHealthcare / Biotechnology / USA
1.06+0.10+10.42%Vol 174 1041Y Perf -12.50%
Jul 20th, 2018 15:59
BID1.06 ASK1.08
Open0.96 Previous Close0.96
Pre-Market1.00 After-Trading1.20
 0.04 4.17%  0.14 13.21%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★★★     70.10
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)- 
Earnings Rating
Price Range Ratio 52wk %
63.33 
Earnings Date

Today's Price Range

0.941.26

 

52wk Range

0.111.61

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
165.00%
3 Months
324.00%
6 Months
16.48%
1 Year
-12.50%
3 Years
-51.60%
5 Years
2.35%

Quotes

Name / TickerPriceChg.Chg.%
CELGZ1.060.100010.42
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.20
Current Ratio 2.50
Long Term Debt to Total Capital 0.80
Total Debt to Equity 3.92
Interest Coverage 8.70
Leverage Ratio 5.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin96.40
EBIT Margin36.00
EBITDA Margin39.60
Pre-tax Profit Margin26.40
Profit Margin17.32
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio -
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -
Cash Flow Per Share -
Price to Tangible Book-
Book Value per Share-
Enterprise Value (in ths.)-
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)32.16
ROE last 12 Months 44.54
Return on Assets (5Y Avg) 6.28
ROA last 12 Months 9.01
Return on Capital (5Y Avg) 14.26
ROC last 12 Months 13.47
Return on invested Capital Q 3.93
Return on invested Capital Y14.95
Assets Turnover0.10
Receivables Turnover2.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)10 298 000
Revenue per Share -
Revenue Growth 3 Years 12.48
Revenue Growth 5 Years 16.48
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume174 104
Shares Outstanding (in ths.)0
Trades Count183
Dollar Volume175 974
Avg. Volume23 207
Avg. Weekly Volume55 919
Avg. Monthly Volume25 890
Avg. Quarterly Volume18 495

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

73%27%

Bearish Bullish

59%41%

Bearish Bullish

67%33%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News

x